Retraction—Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis

The costly hydroxychloroquine battle in Brazil

Nogueira, F., & Brito, J. C. (2020) · Journal of Evidence-Based Healthcare · doi:10.17267/2675-021xevidence.v2i1.3054 · Cited by 2

COVID-19 Pneumonia in Patients with Chronic Myocarditis (Recurrent Infectious Immune): Specifics of the Diseases Course, the Role of Basic Therapy (Part 1)

Blagova, O. V., Varionchik, N. V., Берая, М. М., Зайденов, В. А., Коган, Е. А., Sarkisova, N. D., & Nedostup, A. V. (2020) · Rational Pharmacotherapy in Cardiology · doi:10.20996/1819-6446-2020-08-16 · Cited by 2

DESAFIOS, IMPACTOS EMOCIONAIS E FISIOLÓGICOS DURANTE A PANDEMIA COVID19

Santos, D. S., Silva, P. H. S., da Silva, M. L. G., da Silva, J. C. S., Ferreira, M. S., dos Santos, Ú. P. P., & de Souza, T. (2020) · Stricto Sensu Editora eBooks · doi:10.35170/ss.ed.9786586283358.05 · Cited by 2

Potential harm caused by physicians' a-priori beliefs in the clinical effectiveness of hydroxychloroquine and its impact on clinical and economic outcome – A simulation approach

Ebm, C. C., Carfagna, F., Edwards, S., Mantovani, A., & Cecconi, M. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.12.003 · Cited by 2

Craze for Publishing Research in “Foreign” Journals

Kumar, S. (2021) · Medical Journal of Dr D Y Patil Vidyapeeth · doi:10.4103/mjdrdypu.mjdrdypu_319_20 · Cited by 2

Safety and Efficacy of Chloroquine/Hydroxychloroquine in SARS-CoV-2 Infection

Boretti, A. A. (2021) · Asian Journal of Chemistry · doi:10.14233/ajchem.2021.23141 · Cited by 2

Halting 'research waste'

Shamsoddin, E., Sofi‐Mahmudi, A., Natoli, V., Franchi, T., & Tovani‐Palone, M. R. (2021) · BDJ · doi:10.1038/s41415-021-3488-8 · Cited by 2

How did research article publications on the COVID-19 pandemic progress in the Q1 ranked SCImage index journals in 2020?

Daş, T., & Buğra, A. (2022) · Journal of Health Sciences and Medicine · doi:10.32322/jhsm.1034087 · Cited by 2

A Preliminary Survey on the Oral Manifestation of COVID-19 in the First and Second Waves in Bhubaneswar, City of Odisha, India

Bhuyan, R., Bhuyan, S. K., Mohanty, J. N., Panda, N. R., Bhuyan, V., Ojha, P., Priyadarshini, P., & Sahoo, G. (2022) · National Journal of Community Medicine · doi:10.55489/njcm.130520221617 · Cited by 2

The cross‐over of statistical thinking and practices: A pandemic catalyst

Garrett, A. (2022) · Pharmaceutical Statistics · doi:10.1002/pst.2221 · Cited by 2

Translatability scoring in prospective and retrospective COVID drug development cases

Wendler, A., & Wehling, M. (2023) · European Journal of Clinical Pharmacology · doi:10.1007/s00228-023-03517-0 · Cited by 2

Obstructive sleep apnea (OSA) should be considered a comorbidity as a risk factor for COVID-19 fatality: A review. Part II

Rivera-Castaño, L. (2021) · Revista de Fomento Social · doi:10.24875/rmn.20000122 · Cited by 2

Novel biomedical research must not be a work of fiction

Lazar, M. A. (2021) · Journal of Clinical Investigation · doi:10.1172/jci150827 · Cited by 2

Monitoring clinical trials in infectious diseases

DeMets, D. L., Fleming, T. R., & Ellenberg, S. S. (2021) · doi:10.46439/allergy.2.019 · Cited by 2

Guiding Difficult Decisions on Scarce Investigational Therapeutic Agents in the COVID-19 Pandemic

Hamilton, K. W. (2020) · The American Journal of Bioethics · doi:10.1080/15265161.2020.1795548 · Cited by 2

Dissemination of Information During Public Health Crises: Early COVID ‐19 Data From The Laryngoscope

Chern, A., & Selesnick, S. H. (2020) · The Laryngoscope · doi:10.1002/lary.29147 · Cited by 2

Risk of QT-Interval Prolongation From Off-Label COVID-19 Treatments: A Single-Center Experience

Campoy, N. R., Ball, K. M., Foster, T., Morris, K. L., Joshi, S. A., & Cochard, E. (2020) · Consultant · doi:10.25270/con.2020.10.00011 · Cited by 2

Hypothesis: What is the Best We Can Do with Hydroxychloroquine for COVID-19?

Wang, S., Mulier, S., Jonscher, C., Ye, S., Chen, L., Feng, Y., Li, Y., & Ni, Y. (2020) · Clinical Epidemiology · doi:10.2147/clep.s277889 · Cited by 2

Research on repurposed antivirals currently available in Colombia as treatment alternatives for COVID-19

Gómez-Ríos, D., López-Agudelo, V. A., Urrego-Sepúlveda, J. C., & Ramírez-Malule, H. (2021) · Ingeniería y Competitividad · doi:10.25100/iyc.v23i1.10290 · Cited by 2

Management of COVID-19 in cancer patients receiving cardiotoxic anti-cancer therapy. Future recommendations for cardio-oncology

Kobat, H., Elkonaissi, I., Dorak, M. T., & Nabhani‐Gebara, S. (2021) · Oncology Reviews · doi:10.4081/oncol.2021.510 · Cited by 2

Impact of Treatment Regimens on Antibody Response to the SARS-CoV-2 Coronavirus

Shang, Y., Liu, T., Li, J., Kaweme, N. M., Wang, X., & Zhou, F. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.580147 · Cited by 2

Hydroxychloroquine for Prevention of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: Challenges to Trial Conduct During the Global Pandemic

Goldman, J. D. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1707 · Cited by 2

Vaccine Against SARS-COV-2, Questions Arising: Just Another Citizen’s Opinion

Alakpa, G. E. (2021) · Advances in Bioscience and Bioengineering · doi:10.11648/j.abb.20210902.16 · Cited by 2

Coronavirus Disease 2019 (COVID-19) Mechanical Ventilation Research Theme Analysis: Co-word Cluster Analysis

Chen, H., Huang, X., Chen, S., Zhu, W., Huang, W., & Chen, K. (2020) · Journal of College of Physicians And Surgeons Pakistan · doi:10.29271/jcpsp.2020.supp2.94 · Cited by 2

Letter: online search trends suggest patient concerns around immunosuppression use in inflammatory bowel disease during COVID‐19 in the United Kingdom

Quraishi, M. N., Segal, J. P., Cooney, R. M., Kennedy, N. A., Ainley, R., Sharma, N., Bhala, N. B., & Brookes, M. (2020) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.15951 · Cited by 2

Editorial: Fifty Campbell systematic reviews relevant to the policy response to COVID-19

Aloe, A. M., Barends, E. G. R., Besharov, D. J., Bhutta, Z. A., Cai, X., Gaarder, M. M., Garside, R., Haddaway, N., Kristjansson, E., Maynard, B. R., et al. (2020) · Campbell Systematic Reviews · doi:10.1002/cl2.1107 · Cited by 2

Existence of Differential Belief Profiles of COVID-19 Narratives: The Role of Trust in SciencePreprint

Agley, J. D., & Xiao, Y. (2020) · doi:10.21203/rs.3.rs-35919/v1 · Cited by 2

Dampak pandemi coronavirus disease 2019 terhadap kualitas publikasi ilmiah

Yenny, Y. (2021) · Jurnal Biomedika dan Kesehatan · doi:10.18051/jbiomedkes.2021.v4.1-4 · Cited by 2

Retractions and controversies over coronavirus research show that the process of science is working as it should

O’Brian, M. R. (2020) · doi:10.64628/aai.nhen3f9gj · Cited by 2

Treatment and therapeutic agents

Akhtar, I. N. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-824409-8.00002-3 · Cited by 1

Protective Effect of Amantadine in a COVID-19 Patient: Case Report

Borra, A. C. (2020) · Research and Reviews of Infectious Diseases · doi:10.36959/719/575 · Cited by 1

When Science Races: the Standard of Care and Medical Negligence in the Times of Covid-19

Šolc, M. (2022) · Wroclaw Review of Law Administration & Economics · doi:10.2478/wrlae-2022-0001 · Cited by 1

Remdesivir in Severe Cases of COVID-19 Infection

Boretti, A. A. (2024) · Current Organocatalysis · doi:10.2174/0122133372290992240409084133 · Cited by 1

AI and Deepfakes: An Examination of Educational Interventions in Combating Deepfake-Based Disinformation

Dupuis, M., Sung, H., & Long, S. (2025) · IEEE Annual Ubiquitous Computing, Electronics & Mobile Communication Conference (UEMCON) · doi:10.1109/uemcon67449.2025.11267666 · Cited by 1

Approval delays in multi-country COVID-19 trials: the case of COPCOV and the risk of therapeutic inertia

Winters, J., & Schilling, W. H. (2025) · Trials · doi:10.1186/s13063-025-09300-z · Cited by 1

Instigation and Adherence to the Quality Assurance Program to Avoid Academic Conflicts

Battu, P., Mody, B., Rana, S., & Sharma, K. (2021) · Springer eBooks · doi:10.1007/978-981-16-3074-3_8 · Cited by 1

Hesitancy Regarding Medical Advice on COVID-19: An Emergency Department Perspective

Yılmaz, S., Colak, F. U., Hökenek, N. M., & Ak, R. (2022) · Disaster Medicine and Public Health Preparedness · doi:10.1017/dmp.2022.18 · Cited by 1

The Social Protection for Persons with Disabilities during the COVID-19 Pandemic

Probosiwi, R., & Fitriana, K. N. (2022) · IJDS Indonesian Journal of Disability Studies · doi:10.21776/ub.ijds.2022.009.01.02 · Cited by 1

Réhabiliter les impasses scientifiques : Gaffex, un projet de plateforme dédiée aux résultats négatifs

Gallon, G., & Rascol, E. (2021) · Bulletin des Bibliothèques de France eBooks · doi:10.3917/bbf.colle.2020.01.0110 · Cited by 1

Use of a rapid triage assessment tool to discriminate the need for hospitalisation in patients with severe COVID-19 infection presenting to an outpatient clinic: a single-centre, prospective cohort study

Owens, C., Lamb, C. C., Sanchez, J., Quintero, M., & Lopez-Yunez, A. M. (2023) · BMJ Open · doi:10.1136/bmjopen-2023-073781 · Cited by 1

Designing, refining and reflecting on 3 years of daily evidence surveillance for Australia's living national COVID‐19 guidelines

McDonald, S. J., & Turner, T. (2024) · Cochrane Evidence Synthesis and Methods · doi:10.1002/cesm.12045 · Cited by 1

Use of real-world evidence in the Medicare Drug Price Negotiation Program: A checklist for the Centers for Medicare and Medicaid Services and manufacturers

Tunis, S. R., Shafrin, J. T., Than, K., Whittington, M. D., Willke, R., & Bharmal, M. F. (2025) · Health Affairs Scholar · doi:10.1093/haschl/qxaf030 · Cited by 1

Increasing publications count by falsifying, fabricating, and misconducting research data. Is it worth it?

Khalifa, A. A., & Farouk, O. A. (2024) · The Egyptian Orthopaedic Journal · doi:10.4103/eoj.eoj_61_24 · Cited by 1

Inaugural Lifestyle Medicine Editorial

Birrell, F. N. (2020) · Lifestyle Medicine · doi:10.1002/lim2.1 · Cited by 1

Where and when were the studies conducted? An examination of articles published in 2017-2018 in two leading Indian psychiatry journals

Andrade, C., Arya, T., & Sivakumar, K. (2020) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2020.102283 · Cited by 1

Antimalarial and cytotoxic drugs on COVID-19 and the cardiovascular burden: Literature review and lessons to be learned

Sultan, S., & Acharya, Y. (2020) · Vascular · doi:10.1177/1708538120941635 · Cited by 1

Desperate times call for evidence-based measures: Prioritizing science during the COVID-19 pandemic

Chagla, Z., Laupland, K. B., & Schwartz, I. S. (2020) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2020-06-22 · Cited by 1

Chloroquine and Hydroxychloroquine in SARS-Cov-2. Repurposing the old drugs against today’s deadly disease

Jaiswal, K., Dudhgaonkar, S., Raghute, L., Kewalramani, M. S., & Vaishnao, L. S. (2020) · Journal of Pharmaceutical and Biological Sciences · doi:10.18231/j.jpbs.2020.001 · Cited by 1

An Ounce of Prevention and a Pound of Cure: Randomized Clinical Trials of Therapeutics Against COVID-19 and an Assessment of Personal Protective Equipment and Distancing

Sher, D. J. (2020) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2020.08.001 · Cited by 1

Crise sanitaire et crise réflexive : le regard médical en temps d’épidémie

Galtier, J., & Riviere, E. L. (2020) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2020.08.001 · Cited by 1

Ciencia bajo estrés. Efectos de la pandemia sobre la investigación

Estrada, J. L. N. (2020) · Revista Argentina de Cardiología · doi:10.7775/rac.es.v88.i3.18282 · Cited by 1

Identifying the Quality Nuggets Amid the Explosion of COVID-19-Related Scientific Communication: An Insurmountable Challenge?

Oud, L. (2020) · Journal of Clinical Medicine Research · doi:10.14740/jocmr4328 · Cited by 3

Revisiting cardiac safety of hydroxychloroquine in rheumatological diseases during COVID-19 era: Facts and myths

Padiyar, S., & Danda, D. (2020) · European Journal of Rheumatology · doi:10.5152/eurjrheum.2020.20174 · Cited by 1

Renin--angiotensin system blockers and the risk of critical or fatal coronavirus disease 2019 in African Americans

Thomopoulos, C., & Michalopoulou, H. (2020) · Journal of Hypertension · doi:10.1097/hjh.0000000000002636 · Cited by 1

Large-scale use of hydroxychloroquine for COVID-19 confirms safety, if not effectiveness

Cavalli, G., & Dagna, L. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.10.023 · Cited by 1

DISCURSO ANTICIENTÍFICO E COVID-19: TENSÕES ENTRE POLÍTICA E JORNALISMO

Fetter, G. L. (2020) · Macabéa - Revista Eletrônica do Netlli · doi:10.47295/mren.v9i4.2672 · Cited by 1

METODOLOGIA DIGITAL E APRENDIZAGEM POR PARES APLICADAS À EDUCAÇÃO EM SAÚDE SEXUAL PARA UNIVERSITÁRIOS DURANTE A PANDEMIA DA COVID-19: RELATO DE EXPERIÊNCIA

do Carmo, B. O., Machado, C. M. G., de Souza, D. R. F., Gomes, E. B. F., Pereira, I. M. M., Cunha, M. F. C., de Freitas, S. M. S., Afonso, T. D. O., de Vasconcelos, A. S., & de Araújo, E. G. (2020) · Stricto Sensu Editora eBooks · doi:10.35170/ss.ed.9786586283358.09 · Cited by 1

The Dangers of Non-pharmacological Interventions

Ninot, G. (2020) · Springer eBooks · doi:10.1007/978-3-030-60971-9_5 · Cited by 1

The Effect of Hydroxychloroquine on In-Hospital Mortality in COVID-19

Aboulenain, S., Dewaswala, N., Ramos, F., Torres, P., Abdallah, A., Qader, M. A., Abbasi, B. A., Bornmann, C. R., Dziadkowiec, K. N., Chen, K., et al. (2020) · HCA Healthcare Journal of Medicine · doi:10.36518/2689-0216.1169 · Cited by 1

USO DO INSTAGRAM COMO FERRAMENTA DE ENSINO EM TEMPOS DE COVID-19

Campos, F. F., & Santana, S. S. (2020) · Stricto Sensu Editora eBooks · doi:10.35170/ss.ed.9786586283358.13 · Cited by 1

SOLUÇÃO DE BICARBONATO DE SÓDIO NO TRATAMENTO DA COVID-19 NA AMAZÔNIA OCIDENTAL: CASO CLINICO

Fontes, T. D. N., da Silva, M. D. C. S., Prado, Ú. M., Dantas, T. C., Soares, L. E. P., Saraiva, D. J., de Almeida, A. B., Goncalves, J. S. R. M. D. O., Brilhante, A. F., Lobato, C. M. D. O., et al. (2020) · Stricto Sensu Editora eBooks · doi:10.35170/ss.ed.9786586283358.02 · Cited by 1

“Publish or Perish”; time to question an age old adage?

Sanghvi, D. (2021) · Indian journal of radiology and imaging - new series/Indian journal of radiology and imaging/Indian Journal of Radiology & Imaging · doi:10.4103/ijri.ijri_487_20 · Cited by 1

The weekly cycle of mortality among patients with COVID-19

Nano City Holdings Berhad, N. 1., & М., T. (2021) · Problems of Social Hygiene Public Health and History of Medicine · doi:10.32687/0869-866x-2021-29-1-14-24 · Cited by 1

COVID-19 Treatments Based on Pathogenicity

Asl, A. S., Malekzadeh, F., Nikpoor, A. R., Kermaninezhad, S., & Montazerghaem, S. (2022) · Disease and Diagnosis · doi:10.34172/ddj.2022.23 · Cited by 1

Knowledge on Hydroxychloroquine Prescription and Attitude toward its use in COVID-19 - A Survey-Based Study among Doctors

Afra, T. P., Uvais, N. A., Bishnoi, A., Edavalath, S., Eliyas, S. K., Hafi, B. N., & Muhammed Razmi, T. (2020) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_184_20 · Cited by 1

Review of COVID-19 in Children Admitted to King Fahad Hospital, Albaha, Saudi Arabia in 2020

Almawazini, A. M. (2022) · Journal of Health and Medical Sciences · doi:10.31014/aior.1994.05.01.203 · Cited by 1

How Open Access Publishing Developed in the 2010s and the Potential for Publishing Misconduct

Wallace, W. A., & Ollivere, B. J. (2022) · Springer eBooks · doi:10.1007/978-3-030-99680-2_50 · Cited by 1

HEKİM FAALİYETLERİNDE YAPAY ZEKA TARAFINDAN KARAR DESTEĞİ” FEDERAL TABİPLER BİRLİĞİ ETİK KURULUNUN TIP VE SINIR ALANLARINDA ETİK İLKELERİN KORUNMASINA İLİŞKİN (MERKEZİ ETİK KURULU) GÖRÜŞÜ

TURHAN, E. N. (2022) · Süleyman Demirel Üniversitesi Hukuk Fakültesi Dergisi · doi:10.52273/sduhfd..1227517 · Cited by 1

Antimalarials and macrolides: a review of off-label pharmacotherapies during the first wave of the SARS-CoV-2 pandemic

Ferreira, P. M. P., de Sousa, R. W. R., Dittz, D., Sousa, J. M. D. C. E., Torres‐Leal, F. L., & Bezerra, D. P. (2023) · Brazilian Journal of Pharmaceutical Sciences · doi:10.1590/s2175-97902023e21067 · Cited by 1

Countries should aim to lower the reproduction number ℛ close to 1.0 for the short-term mitigation of COVID-19 outbreaksPreprint

Hochberg, M. (2020) · medRxiv · doi:10.1101/2020.04.14.20065268 · Cited by 1

COVID-19 and hydroxychloroquine: Let the available data speak for themselves

Paliani, U., & Cardona, A. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.07.017 · Cited by 1

Obesity, the Cinderella of Clinical Medicine

Grunauer, M., & Guevara‐Aguirre, J. (2020) · Critical Care Medicine · doi:10.1097/ccm.0000000000004566 · Cited by 1

The cardiac effects of SARS-CoV2: COVID-19 special issue

Camm, C. F., & Camm, A. J. (2020) · European Heart Journal - Case Reports · doi:10.1093/ehjcr/ytaa351 · Cited by 1

Medical Staff Responses to COVID-19 ‘Data’: Have We Misplaced Our Skeptic's Eye?

Meisenberg, B. R. (2020) · The American Journal of Medicine · doi:10.1016/j.amjmed.2020.09.013 · Cited by 1

Reply to “Antiviral and anti-inflammatory properties of ivermectinand its potential use in Covid-19”

Accinelli, R. A., Portmann-Baracco, A., & Bryce‐Alberti, M. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbr.2020.11.002 · Cited by 1

Low Dose Hydroxychloroquine is Associated with Lower Mortality in COVID-19: A Meta-Analysis of 27 Studies and 44,684 PatientsPreprint

Castelnuovo, A. F. D., Costanzo, S., Cassone, A., Cauda, R., de Gaetano, G., & Iacoviello, L. (2020) · doi:10.21203/rs.3.rs-107101/v1 · Cited by 1

Transparency in research and publications on COVID-19

Souza, A. S. R., Fernandes, A. S., Vanderlei, L. C. D. M., da Costa, A. A. R., Ferreira, A. L. C. G., Dubeux, L. S., Braga, C., & Filho, J. E. C. (2021) · Revista Brasileira de Saúde Materno Infantil · doi:10.1590/1806-9304202100s100001 · Cited by 1

En respuesta a «Propiedades antivirales y antiinflamatorias de ivermectina y su potencial uso en COVID-19»

Accinelli, R. A., Portmann-Baracco, A., & Bryce‐Alberti, M. (2020) · Archivos de Bronconeumología · doi:10.1016/j.arbres.2020.09.004 · Cited by 1

Comment on “Problems With Open Access Publishing in Radiology”: Importance of Discerning Medical Publications

Lizarazo, D. A., Triana, G. A., & González‐Gómez, S. (2021) · American Journal of Roentgenology · doi:10.2214/ajr.20.25347 · Cited by 1

Integridad científica: el grito del silencio en medio del embate de la pandemia por la COVID-19

Cabezas, C. (2021) · Anales de la Facultad de Medicina · doi:10.15381/anales.v82i2.21027 · Cited by 1

Research integrity in times of pandemic

de Jesus-Silva, S. G., & Antônio, A. C. P. (2021) · REVISTA CIÊNCIAS EM SAÚDE · doi:10.21876/rcshci.v11i3.1220 · Cited by 1

Trust, but thoroughly verify

(2020) · Nature Biomedical Engineering · doi:10.1038/s41551-020-0596-8 · Cited by 1

Identification and Development of Therapeutics for COVID-19.Preprint

Rando, H. M., Wellhausen, N., Ghosh, S., Lee, A. J., Dattoli, A. A., Hu, F., Byrd, J. B., Rafizadeh, D. N., Lordan, R., Qi, Y., et al. (2021) · PubMed · Cited by 1

La lutte contre la fraude scientifique : une tâche ingrate mais nécessaire

Barrière, J., Frank, F., Besançon, L., Samuel, A., Saada, V., Billy, E., Seitz‐Polski, B., & Robert, J. (2022) · Bulletin du Cancer · doi:10.1016/j.bulcan.2022.06.013 · Cited by 1

Repercussions of the COVID-19 pandemic for science and for the management of the Jornal Brasileiro de Pneumologia

Baldi, B. G., & Pizzichini, M. M. M. (2022) · Jornal Brasileiro de Pneumologia · doi:10.36416/1806-3756/20220429 · Cited by 1

Systematic benefit-risk assessment for the use of chloroquine or hydroxychloroquine as a treatment for COVID-19: Establishing a dynamic framework for rapid decision-makingPreprint

Osborne, V., Davies, M., Dhanda, S., Roy, D., Lane, S., Evans, A., & Shakir, S. (2020) · medRxiv · doi:10.1101/2020.05.07.20093989

Editorial commentary: Hitting a moving target: The challenge of creating consensus treatment protocols for cardiovascular care during the coronavirus pandemic

Yang, E., & Marine, J. E. (2020) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2020.06.002

Women in Hypertension Research Committee and New Investigator Committee Report:Representation of the ISH Women in Hypertension Research and New Investigator and Mentorship Committees at the 14th Meeting of the Indonesian Society of Hypertension (INASH)

Steckelings, U. M., & Charchar, F. (2020) · Hypertension News · doi:10.30824/2006-1

CLOROQUINA E HIDROXICLOROQUINA COMO OPÇÕES PARA TRATAR A COVID-19: CHLOROCHINE AND HYDROXYCHLOROCHINE AS OPTIONS TO TREAT COVID-19

Rabelo, M. L. D. F. (2020) · DOAJ (DOAJ: Directory of Open Access Journals)

Observations on article on healthcare workers & SARS-CoV-2 infection

Kulkarni, A. (2020) · The Indian Journal of Medical Research · doi:10.4103/ijmr.ijmr_2649_20

SARS-CoV-2 infection and some controversies concerning therapy with chloroquine and hydroksychloroquine: case report and selected literature review

Ciepłucha, H. D., & Knysz, B. (2020) · Postępy Higieny i Medycyny Doświadczalnej · doi:10.5604/01.3001.0014.3589

Racionalidade científica versus (ir)racionalidade governamental brasileira: um ensaio sobre algumas crises em tempos de pandemia da COVID-19

Vilaça, M. M., & Palma, A. (2020) · Diversitates International Journal · doi:10.53357/eqon3579

COVID-19 e o Coração

Feitosa, G. S., de Souza, I. P. M. A., Marques, F., Andrade, M. V., Pereira, T., Almeida, A., Soares, F., Silva, R., Magalhães, A., Araújo, B., Jr., et al. (2020) · Revista Científica Hospital Santa Izabel · doi:10.35753/rchsi.v4i2.174

Covid-19 Misinformation Alert, or: “Wash Your Hands and Eat Your Veggies!”

Fadeel, B. (2020) · Frontiers in Toxicology · doi:10.3389/ftox.2020.00004

Evidence-based approaches to comparing the effectiveness of modern cardiology interventions: trends, bias and prospects

Gilyarevsky, S. R., & Belenkov, Y. N. (2020) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2020-4037

Preface to the October 2020 issue of BMJ Military Health : can the raw data from military submissions ever be fully accessible?

Breeze, J. (2020) · BMJ Military Health · doi:10.1136/bmjmilitary-2020-001616

Reduced standards of scientific reporting in the COVID-19 pandemic?

Stöllberger, C., Finsterer, J., & Schneider, B. (2020) · Minerva Cardiology and Angiology · doi:10.23736/s0026-4725.20.05443-2

Conflict Is in the Eye of the Beholder

Toledo, P., & Banayan, J. M. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005222

COVID-19: A CRIAÇÃO DE HISTÓRIAS EM HQS COMO ESTRATÉGIA DE ORIENTAÇÃO PEDAGÓGICA PARA O ENSINO À DISTÂNCIA DOS ALUNOS DO INSTITUTO FEDERAL DE RONDÔNIA, COLORADO DO OESTE, RO

da Costa, P. B. A. F. (2020) · Stricto Sensu Editora eBooks · doi:10.35170/ss.ed.9786586283358.04

Tribulaciones de la investigación en los tiempos de covid-19

Gaitán‐Duarte, H. (2020) · Revista Colombiana de Obstetricia y Ginecología · doi:10.18597/rcog.3621

On the Importance of Data Transparency

Callaghan, S. (2020) · Patterns · doi:10.1016/j.patter.2020.100070 · Cited by 6

News in Brief

Passi, G. R. (2020) · Indian Pediatrics · doi:10.1007/s13312-020-1908-5

Learning from a retraction

The Editors of the Lancet Group (2020) · The Lancet · doi:10.1016/s0140-6736(20)31958-9 · Cited by 50

Data from Mehra et al. (2020-05-29), "Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis"

Mehra, M. R., Desai, S. S., Ruschitzka, F. T., & Patel, A. N. (2020) · Zenodo (CERN European Organization for Nuclear Research) · doi:10.5281/zenodo.3870966

Zweifelhafte COVID-Studien – die Grenzen des Peer Reviews und der Nutzen von Twitter

Nößler, D., & Scherer, M. (2020) · EvidenzUpdate · doi:10.69156/pod.001/2020.06.00035